Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.4K Hold
100
0.02% 246
2025
Q4
$24.1K Hold
100
0.02% 258
2025
Q3
$27.4K Hold
100
0.02% 256
2025
Q2
$25.8K Buy
+100
New +$23.9K 0.02% 252
2024
Q3
$24.4K Hold
100
0.02% 231
2024
Q2
$19.1K Buy
+100
New +$20.3K 0.02% 247
2023
Q3
$29.6K Hold
200
0.03% 210
2023
Q2
$43.7K Buy
+200
New +$44.6K 0.04% 181
2023
Q1
Sell
-250
Closed -$52K 344
2022
Q4
$52K Buy
+250
New +$54.9K 0.04% 188
2022
Q3
Sell
-250
Closed -$52K 328
2022
Q2
$52K Buy
+250
New +$53.2K 0.04% 158
2021
Q1
Sell
-250
Closed -$212 120
2020
Q4
$212 Buy
+250
New +$49.8K 0.06% 51

Other funds holding RMD

WFA of San Diego's RMD Position: Q1 2026 in Review

WFA of San Diego held its ResMed (RMD) position steady in Q1 2026 at 100 shares worth $22.4K. The position accounts for 0.02% of the portfolio, ranked #246.

WFA of San Diego first reported a position in RMD in Q4 2020 and has held it in 11 quarters since. The position peaked at $52K in Q4 2022. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • WFA of San Diego held 100 shares of ResMed worth $22.4K as of Q1 2026.
  • WFA of San Diego left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 0.02% of WFA of San Diego's portfolio in Q1 2026, its #246 holding.
  • WFA of San Diego first reported a position in ResMed in Q4 2020 and has held it in 11 quarters since.
  • WFA of San Diego's ResMed position peaked at $52K in Q4 2022.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on WFA of San Diego's 13F filing for Q1 2026, filed 11 May 2026.